14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AHMA vs PAVS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, AHMA (AHMA) is the stronger overall head-to-head candidate over Paranovus Entertainment Technology Ltd. Class A (PAVS) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AHMA carries a Unified Composite Score of 41.2/100 (SELL) at $1.11 (N/M Forward P/E, 6.4% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin).
Composite vs. Pillar Nuance: While PAVS currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. AHMA 41.2/100 SELL), AHMA captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (6.4% vs. -23.1% operating margin) and revenue trajectory (+4.6% vs. +70798.0% YoY).
Technical & Structure Timing Caution: AHMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.8); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AHMA vs PAVS. Trailing 12-month operating profitability (AHMA 6.4% vs PAVS -23.1%) and valuation multiples (AHMA N/M vs PAVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Footwear & Accessories value chain with $2.2M market capitalization and -23.1% operating margin.
OpEx & R&D Reinvestment39.6% of Rev ($5.8M)
90D Engineering Disclosures0 Published
Investor FAQ AHMA vs PAVS Key Questions & Quantitative Answers
As of Nov 16, 2026, AHMA (AHMA) is the stronger overall head-to-head candidate over Paranovus Entertainment Technology Ltd. Class A (PAVS) in the Tradestie Institutional Equity Comparison Engine, winning 6–3 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AHMA carries a Unified Composite Score of 41.2/100 (SELL) at $1.11 (N/M Forward P/E, 6.4% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin). Composite vs. Pillar Nuance: While PAVS currently prints a higher short-term Unified Composite Score (45.5/100 HOLD vs. AHMA 41.2/100 SELL), AHMA captures the overall institutional head-to-head verdict (6–3 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (6.4% vs. -23.1% operating margin) and revenue trajectory (+4.6% vs. +70798.0% YoY). Technical & Structure Timing Caution: AHMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 43.8); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
AHMA leads the Growth & Scale pillar: AHMA posts +4.6% YoY revenue growth and +4.2% YoY earnings growth on $20M TTM revenue (24.9% gross margin, 6.4% operating margin), compared with PAVS at +70798.0% YoY revenue growth and +0.0% YoY earnings growth on $15M TTM revenue (16.5% gross margin, -23.1% operating margin). On trailing 12-month operating scale, AHMA generates $20M in USD-normalized revenue versus $15M for PAVS. In operating R&D and SG&A reinvestment, AHMA deploys 18.5% of Rev ($3.7M) (0 90-day corporate R&D disclosures) versus 39.6% of Rev ($5.8M) (0 disclosures) for PAVS.
AHMA and PAVS trade at balanced relative valuation multiples. AHMA trades at N/M Forward P/E, 28.8x Trailing P/E, N/M PEG, and 1.7x EV/Revenue (6.9% EBITDA margin), whereas PAVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-8.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AHMA (13.0% ROE) versus PAVS (-50.7% ROE) capital efficiency.
In options market volatility and institutional positioning, AHMA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.28β · 65% Vol realized risk). By comparison, PAVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (113.43β · 116% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.